| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695751 | Gynecologic Oncology | 2017 | 9 Pages |
Abstract
ALT-803 enhances NK cell cytotoxicity against ovarian cancer in vitro and in vivo and is able to rescue functionality of NK cells derived from ovarian cancer patient ascites. These findings suggest that ALT-803 has the potential to enhance NK cell-based immunotherapeutic approaches for the treatment of ovarian cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
M. Felices, S. Chu, B. Kodal, L. Bendzick, C. Ryan, A.J. Lenvik, K.L.M. Boylan, H.C. Wong, A.P.N. Skubitz, J.S. Miller, M.A. Geller,